[go: up one dir, main page]

IT1282733B1 - Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico - Google Patents

Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico

Info

Publication number
IT1282733B1
IT1282733B1 IT96MI001010A ITMI961010A IT1282733B1 IT 1282733 B1 IT1282733 B1 IT 1282733B1 IT 96MI001010 A IT96MI001010 A IT 96MI001010A IT MI961010 A ITMI961010 A IT MI961010A IT 1282733 B1 IT1282733 B1 IT 1282733B1
Authority
IT
Italy
Prior art keywords
alpha
pharmaceutical compositions
compositions containing
acid ester
glycerophosphoric acid
Prior art date
Application number
IT96MI001010A
Other languages
English (en)
Inventor
Alberto Salini
Original Assignee
Flarer S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flarer S A filed Critical Flarer S A
Publication of ITMI961010A0 publication Critical patent/ITMI961010A0/it
Priority to IT96MI001010A priority Critical patent/IT1282733B1/it
Priority to US09/194,002 priority patent/US6194401B1/en
Priority to JP09541525A priority patent/JP2000510857A/ja
Priority to IL12715497A priority patent/IL127154A0/xx
Priority to ZA9704356A priority patent/ZA974356B/xx
Priority to CA002255640A priority patent/CA2255640A1/en
Priority to PCT/EP1997/002553 priority patent/WO1997044053A1/en
Priority to EP97924958A priority patent/EP0901378B1/en
Priority to DE69712055T priority patent/DE69712055D1/de
Priority to AU30276/97A priority patent/AU709068B2/en
Priority to NZ332904A priority patent/NZ332904A/en
Priority to AT97924958T priority patent/ATE216254T1/de
Publication of ITMI961010A1 publication Critical patent/ITMI961010A1/it
Application granted granted Critical
Publication of IT1282733B1 publication Critical patent/IT1282733B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT96MI001010A 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico IT1282733B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico
PCT/EP1997/002553 WO1997044053A1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
DE69712055T DE69712055D1 (de) 1996-05-20 1997-05-20 Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
IL12715497A IL127154A0 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophoshoric acid
ZA9704356A ZA974356B (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid with choline, ethanolamine, serine or inositol.
CA002255640A CA2255640A1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
US09/194,002 US6194401B1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid
EP97924958A EP0901378B1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
JP09541525A JP2000510857A (ja) 1996-05-20 1997-05-20 シクロスポリンと少なくとも一種のアルファ―グリセロリン酸エステルから成るキャリアとを含有する薬剤組成物
AU30276/97A AU709068B2 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
NZ332904A NZ332904A (en) 1996-05-20 1997-05-20 Compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
AT97924958T ATE216254T1 (de) 1996-05-20 1997-05-20 Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico

Publications (3)

Publication Number Publication Date
ITMI961010A0 ITMI961010A0 (it) 1996-05-20
ITMI961010A1 ITMI961010A1 (it) 1997-11-20
IT1282733B1 true IT1282733B1 (it) 1998-03-31

Family

ID=11374287

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico

Country Status (12)

Country Link
US (1) US6194401B1 (it)
EP (1) EP0901378B1 (it)
JP (1) JP2000510857A (it)
AT (1) ATE216254T1 (it)
AU (1) AU709068B2 (it)
CA (1) CA2255640A1 (it)
DE (1) DE69712055D1 (it)
IL (1) IL127154A0 (it)
IT (1) IT1282733B1 (it)
NZ (1) NZ332904A (it)
WO (1) WO1997044053A1 (it)
ZA (1) ZA974356B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US7026290B1 (en) 1998-12-30 2006-04-11 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosprin
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
DE10038699A1 (de) * 2000-07-31 2002-02-14 Michael Sittinger Mittel zur Verringrung der Abstoßungsreaktionen bei Transplantaten
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
KR100966627B1 (ko) * 2006-06-14 2010-06-29 주식회사 대웅제약 L-α-글리세로포스포릴 콜린의 제조방법
EP2300408B1 (en) * 2008-05-08 2016-04-13 United Therapeutics Corporation Process for the preparation of treprostinil monohydrate and its use for storage and shipping
US20110033527A1 (en) * 2009-06-02 2011-02-10 Nian Wu Opthalmic compositions of cyclosporin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515035A1 (fr) 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
JPS5916818A (ja) 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
IT1265647B1 (it) 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
EP0697214A1 (en) * 1994-07-19 1996-02-21 Vestar, Inc. Liposomal cyclosporin pharmaceutical formulations

Also Published As

Publication number Publication date
JP2000510857A (ja) 2000-08-22
AU709068B2 (en) 1999-08-19
ZA974356B (en) 1998-01-14
EP0901378B1 (en) 2002-04-17
DE69712055D1 (de) 2002-05-23
NZ332904A (en) 2000-06-23
EP0901378A1 (en) 1999-03-17
WO1997044053A1 (en) 1997-11-27
IL127154A0 (en) 1999-09-22
ITMI961010A0 (it) 1996-05-20
AU3027697A (en) 1997-12-09
US6194401B1 (en) 2001-02-27
ATE216254T1 (de) 2002-05-15
CA2255640A1 (en) 1997-11-27
ITMI961010A1 (it) 1997-11-20

Similar Documents

Publication Publication Date Title
AU1843297A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
TNSN98075A1 (fr) Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
DE3683823D1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
ES8704443A1 (es) Un procedimiento para la preparacion de derivados sustituidos ester benzoato de 3-hidroximorfinanos.
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
CA2199128A1 (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
IT1282733B1 (it) Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico
HUP9903855A2 (hu) Orális adagolásra való valproesavat tartalmazó gyógyszerészeti mikrogömbök
IT8424209A0 (it) Impiego di esteri dell'acido salicilico come prodotti profumanti composizioni profumate che licontengono, nonche' nuovi esteri dell'acido salicilico.
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
EP0194093A3 (en) Substituted heterocyclic acrylic acids and esters, their preparation and pharmaceutical compositions containing them
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
IL122942A0 (en) Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them
NO983803D0 (no) Fremstilling av (S)-dekahydroisokinolin-3-karboksylsyre t-butylamid
AU1843197A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
MX9806247A (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios.
MX9806249A (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios.
DE69433999D1 (de) Entzündungshemmende peptide
IT1302289B1 (it) Composizioni farmaceutiche ad attivita' antineoplastica
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
ES2187962T3 (es) Derivados estrogenicos de la 19-norandrost-17-ona con un anillo aromatico b.
ES2187963T3 (es) Sales farmaceuticamente aceptables de 3-sulfato de 3-hidroxi-estr-5(10)-en 17-ona activas con estrogenos.
ES2067140T3 (es) Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos.
CA2244245A1 (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
FR2738488B1 (fr) Composition contenant a titre de principe actif au moins un extrait d'au moins une iridacee

Legal Events

Date Code Title Description
0001 Granted